| |
| |
|
| Insider
Information: |
Coyne Terrance P. |
| Relationship: |
EVP & CFO |
| City: |
New York |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
1,500 |
|
|
Indirect Shares
|
838,890 |
|
|
| Direct
Value |
$42,615 |
|
|
|
Indirect Value
|
$23,832,865 |
|
|
| Total
Shares |
840,390 |
|
|
| Total
Value |
$23,875,480 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Royalty Pharma Plc |
RPRX |
EVP & CFO |
2023-08-10 |
1,500 |
2023-08-10 |
838,890 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
15 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| RPRX |
Royalty Pharma Plc |
EVP & CFO |
• – – |
2023-08-10 |
4 |
S |
$30.75 |
$1,153,091 |
I/I |
(37,500) |
790,000 |
0 |
% |
|
| RPRX |
Royalty Pharma Plc |
EVP & CFO |
• – – |
2023-08-09 |
4 |
S |
$30.72 |
$1,151,936 |
I/I |
(37,500) |
827,500 |
0 |
% |
|
| RPRX |
Royalty Pharma Plc |
EVP & CFO |
• – – |
2023-07-13 |
4 |
S |
$30.93 |
$1,159,958 |
I/I |
(37,500) |
865,000 |
0 |
% |
|
| RPRX |
Royalty Pharma Plc |
EVP & CFO |
• – – |
2023-07-12 |
4 |
S |
$31.07 |
$1,165,256 |
I/I |
(37,500) |
902,500 |
0 |
% |
|
| RPRX |
Royalty Pharma Plc |
EVP & CFO |
• – – |
2022-11-08 |
4 |
S |
$43.47 |
$1,065,013 |
I/I |
(24,500) |
940,000 |
0 |
% |
|
| RPRX |
Royalty Pharma Plc |
EVP & CFO |
• – – |
2022-11-02 |
4 |
S |
$43.06 |
$236,846 |
I/I |
(5,500) |
964,500 |
0 |
% |
|
| RPRX |
Royalty Pharma Plc |
EVP & CFO |
• – – |
2022-08-01 |
4 |
S |
$43.19 |
$1,295,727 |
I/I |
(30,000) |
970,000 |
0 |
% |
|
| RPRX |
Royalty Pharma Plc |
EVP & CFO |
• – – |
2021-05-07 |
4 |
A |
$0.00 |
$0 |
I/I |
1,000,000 |
1,000,000 |
0 |
- |
|
| RPRX |
Royalty Pharma Plc |
EVP & CFO |
• – – |
2021-03-03 |
4 |
S |
$43.71 |
$4,478,450 |
I/I |
(100,000) |
200,000 |
0 |
% |
|
| RPRX |
Royalty Pharma Plc |
EVP & CFO |
• – – |
2021-03-02 |
4 |
S |
$46.89 |
$4,694,090 |
I/I |
(100,000) |
300,000 |
0 |
% |
|
| RPRX |
Royalty Pharma Plc |
EVP & CFO |
• – – |
2020-12-31 |
4 |
A |
$0.00 |
$0 |
I/I |
400,000 |
400,000 |
0 |
- |
|
| RPRX |
Royalty Pharma Plc |
EVP & CFO |
• – – |
2020-06-18 |
4/A |
A |
$0.00 |
$0 |
I/I |
24,170 |
24,170 |
0 |
- |
|
| RPRX |
Royalty Pharma Plc |
EVP & CFO |
• – – |
2020-06-18 |
4 |
A |
$0.00 |
$0 |
I/I |
23,270 |
23,270 |
0 |
- |
|
| RPRX |
Royalty Pharma Plc |
EVP & CFO |
• – – |
2020-06-18 |
4 |
B |
$28.00 |
$40,600 |
I/I |
1,450 |
1,450 |
1.99 |
% |
|
| RPRX |
Royalty Pharma Plc |
EVP & CFO |
• – – |
2020-06-18 |
4 |
B |
$28.00 |
$42,000 |
D/D |
1,500 |
1,500 |
2.74 |
% |
|
15 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
